CC
IRD

Cornerstone Capital’s Opus Genetics IRD Stock Holding History

Cornerstone Capital’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,357
Closed -$61.3K – 94
2023
Q1 		$61.3K Buy
+16,357
New +$58.7K 0.01% 88
2022
Q4 		– Sell
-13,857
Closed -$28K – 94
2022
Q3 		$28K Hold
13,857
– – ﹤0.01% 86
2022
Q2 		$27K Buy
13,857
+2,500
+22% +$5.68K ﹤0.01% 86
2022
Q1 		$37K Hold
11,357
– – ﹤0.01% 90
2021
Q4 		$42K Hold
11,357
– – ﹤0.01% 90
2021
Q3 		$58K Hold
11,357
– – 0.01% 90
2021
Q2 		$60K Buy
+11,357
New +$56.4K 0.01% 92

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Cornerstone Capital's IRD Position: Q2 2023 in Review

Cornerstone Capital sold out of Opus Genetics (IRD) in Q2 2023, closing a stake of 16,357 shares — an estimated $61.3K sold.

Cornerstone Capital first reported a position in IRD in Q2 2021 and held it in 7 quarters. The position peaked at $61.3K in Q1 2023. 49 funds tracked by Wall St. Rank hold IRD as of Q2 2023.

  • Cornerstone Capital reported no remaining Opus Genetics position as of Q2 2023 after selling out during the quarter.
  • Cornerstone Capital sold 16,357 Opus Genetics shares in Q2 2023, an estimated $61.3K.
  • Cornerstone Capital first reported a position in Opus Genetics in Q2 2021 and held it in 7 quarters.
  • Cornerstone Capital's Opus Genetics position peaked at $61.3K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2023.

Based on Cornerstone Capital's 13F filing for Q2 2023, filed 21 Aug 2023.